Signaling Pathways - Substance P/NK1 Receptor - DPP-4 - KDR - P-glycoprotein (P-gp)
清除全部
- B3941 Talabostat mesylate2 CitationTarget: DPP-4Summary: DPP4抑制剂
- B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- A8650 Saxagliptin中文名: 沙格列汀Target: DPP-4Summary: DPP4抑制剂
- A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb(P糖蛋白)抑制剂
- A1684 Aprepitant中文名: 阿瑞匹坦Target: Substance P/NK1 ReceptorSummary: P物质(SP)抑制剂
- A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂
- A3865 Teneligliptin hydrobromide中文名: 氢溴酸替格列汀Target: DPP-4Summary: DDP4抑制剂
- A3859 Tariquidar methanesulfonate, hydrate中文名: 他立喹达二甲磺酸盐六水合物Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂
- A3384 Elacridar中文名: 依克立达Target: P-glycoprotein (P-gp)Summary: BCRP抑制剂